NASDAQ:NXTM - NxStage Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$30.00 0.00 (0.00 %)
(As of 02/21/2019)
Previous Close$30.00
Today's Range$29.98 - $30.00
52-Week Range$23.17 - $30.00
Volume2.61 million shs
Average Volume1.51 million shs
Market Capitalization$2.00 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.25
NxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. The company operates through three segments: System One, In-Center, and Services. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment, as well as sells disposable products in the home and critical care market for the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting and in the critical care market for the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment sells blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers, and needles for apheresis. The Services segment offers dialysis services to patients at NxStage Kidney Care dialysis centers. As of February 3, 2018, it had 21 centers. NxStage Medical, Inc. markets its products through direct sales to dialysis clinics and hospitals in the United States, the United Kingdom, and Canada, as well as through distributors in Europe and internationally. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts.

Receive NXTM News and Ratings via Email

Sign-up to receive the latest news and ratings for NXTM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:NXTM
CUSIP67072V10
Phone978-687-4700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$393.94 million
Cash Flow$0.2911 per share
Book Value$3.22 per share

Profitability

Net Income$-14,470,000.00

Miscellaneous

EmployeesN/A
Market Cap$2.00 billion
Next Earnings DateN/A
OptionableOptionable

NxStage Medical (NASDAQ:NXTM) Frequently Asked Questions

What is NxStage Medical's stock symbol?

NxStage Medical trades on the NASDAQ under the ticker symbol "NXTM."

How were NxStage Medical's earnings last quarter?

NxStage Medical, Inc. (NASDAQ:NXTM) posted its earnings results on Monday, August, 7th. The medical device company reported ($0.03) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.03) by $0.00. The medical device company had revenue of $92.20 million for the quarter, compared to the consensus estimate of $96.47 million. NxStage Medical had a negative return on equity of 2.50% and a negative net margin of 1.29%. NxStage Medical's quarterly revenue was up .0% compared to the same quarter last year. During the same quarter last year, the business earned ($0.03) EPS. View NxStage Medical's Earnings History.

Has NxStage Medical been receiving favorable news coverage?

News stories about NXTM stock have been trending positive this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. NxStage Medical earned a media sentiment score of 2.8 on InfoTrie's scale. They also assigned media stories about the medical device company a news buzz of 5.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the company's share price in the next several days.

Who are some of NxStage Medical's key competitors?

What other stocks do shareholders of NxStage Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NxStage Medical investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Hawkins (HWKN), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), Athabasca Oil (ATH), Och-Ziff Capital Management Group (OZM), Gran Tierra Energy (GTE) and ALJ Regional (ALJJ).

Who are NxStage Medical's key executives?

NxStage Medical's management team includes the folowing people:
  • Mr. Jeffrey H. Burbank, Founder, CEO & Director (Age 56)
  • Mr. Joseph E. Turk Jr., Pres (Age 51)
  • Mr. Matthew W. Towse, Sr. VP, CFO & Treasurer (Age 56)
  • Ms. Winifred L. Swan, Sr. VP, Gen. Counsel & Sec. (Age 55)
  • Dr. Allan J. Collins, Head of Scientific Advisory Board & Chief Medical Officer

How do I buy shares of NxStage Medical?

Shares of NXTM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is NxStage Medical's stock price today?

One share of NXTM stock can currently be purchased for approximately $30.00.

How big of a company is NxStage Medical?

NxStage Medical has a market capitalization of $2.00 billion and generates $393.94 million in revenue each year. The medical device company earns $-14,470,000.00 in net income (profit) each year or ($0.22) on an earnings per share basis.

What is NxStage Medical's official website?

The official website for NxStage Medical is http://www.nxstage.com.

How can I contact NxStage Medical?

NxStage Medical's mailing address is 350 MERRIMACK STREET, LAWRENCE MA, 01843. The medical device company can be reached via phone at 978-687-4700 or via email at [email protected]


MarketBeat Community Rating for NxStage Medical (NASDAQ NXTM)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  334 (Vote Outperform)
Underperform Votes:  281 (Vote Underperform)
Total Votes:  615
MarketBeat's community ratings are surveys of what our community members think about NxStage Medical and other stocks. Vote "Outperform" if you believe NXTM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NXTM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel